Procter & Gamble Hygiene and Health Care Ratios

Procter & Gamble Hygiene and Health Care Ltd Ratios

The Procter & Gamble Hygiene and Health Care Ltd Ratios page provides a complete fundamental analysis of Procter & Gamble Hygiene and Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Procter & Gamble Hygiene and Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Procter & Gamble Hygiene and Health Care Ltd (NSE: PGHH, BSE: 500459) is currently trading at ₹11694, with a market capitalization of ₹378.94B. As a major player in the Consumer non-durables sector and Household/Personal care industry, Procter & Gamble Hygiene and Health Care Ltd remains a key stock for fundamental analysis using Procter & Gamble Hygiene and Health Care Ltd Ratios.

Procter & Gamble Hygiene and Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Procter & Gamble Hygiene and Health Care Ltd P/E ratio currently stands at 69.37, making it one of the most tracked metrics in Procter & Gamble Hygiene and Health Care Ltd Ratios.

Historically, the Procter & Gamble Hygiene and Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 69.37
• 2023: 68.47
• 2022: 75.57
• 2021: 66.38
• 2020: 76.12

The rising Procter & Gamble Hygiene and Health Care Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Procter & Gamble Hygiene and Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 59.92.

Historical P/B trend:

• 2024: 59.92
• 2023: 49.08
• 2022: 58.99
• 2021: 60.58

Procter & Gamble Hygiene and Health Care Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Procter & Gamble Hygiene and Health Care Ltd P/S ratio currently stands at 9.81, an important part of Procter & Gamble Hygiene and Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 9.81
• 2023: 11.85
• 2022: 11.15
• 2021: 12.11

A stable or declining Procter & Gamble Hygiene and Health Care Ltd P/S ratio indicates cautious market sentiment.

Procter & Gamble Hygiene and Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Procter & Gamble Hygiene and Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 71.50.

Historical Procter & Gamble Hygiene and Health Care Ltd Price to Cash Flow Ratio:

• 2024: 71.50
• 2023: 54.30
• 2022: 73.31
• 2021: 48.47
• 2020: 64.39

The rising Procter & Gamble Hygiene and Health Care Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Procter & Gamble Hygiene and Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Procter & Gamble Hygiene and Health Care Ltd EV currently stands at ₹436.8B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 436.8B
• 2023: 454.59B
• 2022: 428.75B
• 2021: 426.11B

Procter & Gamble Hygiene and Health Care Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Procter & Gamble Hygiene and Health Care Ltd EV/EBITDA ratio is currently 36.71, a key metric in Procter & Gamble Hygiene and Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 36.71
• 2023: 52.02
• 2022: 51.12
• 2021: 47.62

Stable Procter & Gamble Hygiene and Health Care Ltd EV/EBITDA indicates balanced valuation.

Procter & Gamble Hygiene and Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Procter & Gamble Hygiene and Health Care Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0.01
• 2021: 0

Procter & Gamble Hygiene and Health Care Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Procter & Gamble Hygiene and Health Care Ltd ROE currently stands at 100.86%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 100.86
• 2023: 80.56
• 2022: 79.31
• 2021: 69.63

Procter & Gamble Hygiene and Health Care Ltd demonstrates strong profitability and efficient capital utilization.

Procter & Gamble Hygiene and Health Care Ltd Ratios Analysis Summary

The Procter & Gamble Hygiene and Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Procter & Gamble Hygiene and Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Procter & Gamble Hygiene and Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.